著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
ZHOU C,"Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802) : a multicentre, open-label, randomised, phase 3 study",Lancet Oncol,,,2011,12,,735-742,https://cir.nii.ac.jp/crid/1570009751429888896,